v3.26.1
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Deficit - USD ($)
$ in Thousands
Total
Previously Reported
Reverse recapitalization
Common Stock
Common Stock
Previously Reported
Common Stock
Reverse recapitalization
Additional Paid-In Capital
Additional Paid-In Capital
Previously Reported
Additional Paid-In Capital
Reverse recapitalization
Accumulated Deficit
Accumulated Deficit
Previously Reported
Accumulated Deficit
Reverse recapitalization
Accumulated Comprehensive Income
Accumulated Comprehensive Income
Previously Reported
Accumulated Comprehensive Income
Reverse recapitalization
Beginning balance (in shares) at Dec. 31, 2022 62,240,000 93,963,000 (31,723,000)                        
Beginning balance at Dec. 31, 2022 $ 170,648 $ 170,648 $ 0                        
Ending balance (in shares) at Dec. 31, 2023 62,240,000                            
Ending balance at Dec. 31, 2023 $ 170,648                            
Beginning balance (in shares) at Dec. 31, 2022       57,205,000 86,360,000 (29,155,000)                  
Beginning balance at Dec. 31, 2022 (135,128) $ (135,128) $ 0 $ 6 $ 0 $ 6 $ 6,596 $ 6,602 $ (6) $ (141,740) $ (141,740) $ 0 $ 10 $ 10 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock upon exercise of stock options (in shares)       571,000                      
Issuance of common stock upon exercise of stock options 306           306                
Stock-based compensation 5,399           5,399                
Other comprehensive income (loss) (10)                       (10)    
Net loss (56,945)                 (56,945)          
Ending balance (in shares) at Dec. 31, 2023       57,776,000                      
Ending balance at Dec. 31, 2023 $ (187,098)     $ 6     11,581     (198,685)          
Ending balance (in shares) at Dec. 31, 2024 62,240,000 93,963,000 (31,723,000)                        
Ending balance at Dec. 31, 2024 $ 170,648 $ 170,648 $ 0                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock upon exercise of stock options (in shares)       281,000                      
Issuance of common stock upon exercise of stock options 172           172                
Stock-based compensation 5,550           5,550                
Net loss $ (69,459)                 (69,459)          
Ending balance (in shares) at Dec. 31, 2024 58,057,000     58,057,000 87,646,000 (29,589,000)                  
Ending balance at Dec. 31, 2024 $ (250,835) $ (250,835) $ 0 $ 6 $ 0 $ 6 17,303 17,309 (6) (268,144) (268,144) 0 0    
Ending balance (in shares) at Mar. 31, 2025 62,240,000                            
Ending balance at Mar. 31, 2025 $ 170,648                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock upon exercise of common stock warrants (in shares)       17,000                      
Issuance of common stock upon exercise of stock options (in shares)       942,000                      
Issuance of common stock upon exercise of stock options 508           508                
Stock-based compensation 1,878           1,878                
Net loss (128,185)                 (128,185)          
Ending balance (in shares) at Mar. 31, 2025       59,016,000                      
Ending balance at Mar. 31, 2025 $ (376,634)     $ 6     19,689     (396,329)     0    
Beginning balance (in shares) at Dec. 31, 2024 62,240,000 93,963,000 (31,723,000)                        
Beginning balance at Dec. 31, 2024 $ 170,648 $ 170,648 $ 0                        
Ending balance (in shares) at Dec. 31, 2025 142,000                            
Ending balance at Dec. 31, 2025 $ 223,185                            
Beginning balance (in shares) at Dec. 31, 2024 58,057,000     58,057,000 87,646,000 (29,589,000)                  
Beginning balance at Dec. 31, 2024 $ (250,835) $ (250,835) $ 0 $ 6 $ 0 $ 6 17,303 $ 17,309 $ (6) (268,144) $ (268,144) $ 0 0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock upon exercise of common stock warrants (in shares)       62,240,000                      
Conversion of redeemable convertible preferred stock in connection with reverse recapitalization/Issuance of common stock upon exercise of common stock warrants $ 170,648     $ 6     170,642                
Issuance of common stock upon exercise of stock options (in shares) 2,558,000     2,558,000                      
Issuance of common stock upon exercise of stock options $ 1,434           1,434                
Stock-based compensation 19,452           19,452                
Other comprehensive income (loss) 22                       22    
Net loss $ (585,525)                 (585,525)          
Ending balance (in shares) at Dec. 31, 2025 175,440,000     175,440,000                      
Ending balance at Dec. 31, 2025 $ (283,052)     $ 17     570,578     (853,669)     22    
Ending balance (in shares) at Mar. 31, 2026 142,000                            
Ending balance at Mar. 31, 2026 $ 223,185                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of common stock upon exercise of common stock warrants (in shares)       386,000                      
Conversion of redeemable convertible preferred stock in connection with reverse recapitalization/Issuance of common stock upon exercise of common stock warrants $ 3,584           3,584                
Issuance of common stock upon exercise of stock options (in shares) 1,650,000     1,650,000                      
Issuance of common stock upon exercise of stock options $ 973     $ 1     972                
Stock-based compensation 6,111           6,111                
Other comprehensive income (loss) (24)                       (24)    
Net loss $ 26,490                 26,490          
Ending balance (in shares) at Mar. 31, 2026 177,476,000     177,476,000                      
Ending balance at Mar. 31, 2026 $ (245,918)     $ 18     $ 581,245     $ (827,179)     $ (2)